Empower™ First-Line Hereditary Cancer Testing: Providing Information for Informed Decision-Making
Empower™ is a test by Natera designed to identify hereditary predisposition to various types of cancer.
It analyzes up to 53 genes associated with an increased risk of developing more than 12 types of hereditary cancer.
Empower™ hereditary cancer testing provides you with clarity and confidence when making important decisions on your path toward better health.
Benefits of the Empower™ test:
- Personalized approach: provides individualized information about cancer risks, enabling informed decisions regarding prevention and treatment.
- Information for family members: helps family members understand their own risks and take preventive measures.
- Prevention and screening recommendations: helps develop prevention strategies and determine appropriate screening protocols for the early detection of cancer.
Which cancer risks can be identified with the test:
- Breast cancer
- Ovarian cancer
- Uterine cancer
- Colorectal cancer
- Stomach cancer
- Prostate cancer
- Pancreatic cancer
- Melanoma
Key features of the Empower™ test:
Broad gene coverage:
The test analyzes multiple genes associated with hereditary cancer syndromes, making it possible to identify a predisposition to various types of cancer.
Personalized approach:
The test results help develop individualized prevention, monitoring, and treatment strategies based on the patient’s genetic profile.
Information for family members:
Because certain genetic mutations can be inherited, Empower™ test results provide valuable information not only for the patient but also for their relatives, allowing them to assess their own risks and take appropriate measures.
Simple and convenient:
Testing is performed using a saliva or blood sample, making the sample collection process convenient for the patient.
Variety of testing panels:
| Type of test | Genes | Price (KZT) |
| Hereditary Breast and Ovarian Cancer Syndrome | BRCA1, BRCA2 | 287 000 |
| Lynch Syndrome | MLH1, MSH2, MSH6, PMS2, EPCAM |
310 000 |
| Most common hereditary cancer gene screening panel covering eight types of cancer | View file | 345 000 |
When should you consider hereditary cancer testing?
- Personal or family history of cancer diagnosed before the age of 50
- Personal or family history of ovarian, breast, or pancreatic cancer in men
- Multiple types of cancer or tumors among relatives on the maternal side of the family
- Multiple types of cancer or tumors within the same family on the maternal side
- If you are concerned about other hereditary forms of cancer in your family
Required biological material:
You must provide:
- Venous blood